Integrity Applications, Inc. announced that Paul V. Goode has been appointed as President and Chief Operating Officer, effective November 1, 2021. Paul has served as a member of Integrity?s Board of Directors since December 17, 2020. Concurrent with his new appointment, Mr. Goode will be stepping down from the Board. In this role, Paul will lead the company?s operations, overseeing strategy, design, manufacturing, business and product development and begin to build the U.S. infrastructure in preparation for the U.S. clinical trials of GlucoTrack. Paul is a highly accomplished medical device professional with extensive experience in all areas of operations and product development, from initial concept to global commercialization. During his over twenty-year medical device career, Paul has spent considerable time working with innovative diabetes management technologies, including as Vice President of R&D at MetaCure, a neurostimulator device for Type 2 diabetes; Director of Engineering and Algorithm Development at DexCom; and, as Senior Engineer at MiniMed, Inc.